Showing results (61-70 of 97) with videos related to
Sort By:
Pageof 10
RSC Medicinal Chemistry|September 8, 2025
Parallel synthesis of 5'-amino-5'-deoxy-adenosine derivatives for focused chemical space exploration and their application as methyltransferase inhibitorsSabrina N Hoba, Marvin Schwickert, Luis Kammerer, et al.British Journal of Cancer|October 13, 2022
Early radiologic signal of responsiveness to immune checkpoint blockade in microsatellite-stable/mismatch repair-proficient metastatic colorectal cancerSebastian Meltzer, Anne Negård, Kine M Bakke, et al.Acta Oncologica (Stockholm, Sweden)|June 23, 2016
Palliative pelvic radiotherapy for symptomatic rectal cancer - a prospective multicenter studyMarte G Cameron, Christian Kersten, Ingvild Vistad, et al.RSC Advances|February 23, 2026
Mechanistic profiling and optimized production of Altenusin, a fungal carboxy-biphenyl scaffold for tyrosinase inhibitionNicolas Reyes Castillo, Marius Spohn, Celine M Zumkeller, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 21, 2015
Palliative pelvic radiotherapy for symptomatic incurable prostate cancer – A prospective multicenter studyMarte Grønlie Cameron, Christian Kersten, Ingvild Vistad, et al.Chemmedchem|September 15, 2020
Structure-Activity Relationships of Benzamides and Isoindolines Designed as SARS-CoV Protease Inhibitors Effective against SARS-CoV-2Armin Welker, Christian Kersten, Christin Müller, et al.BMC Cancer|December 25, 2012
Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention studyMarit Synnestvedt, Elin Borgen, Erik Wist, et al.Annals of Surgical Oncology|April 6, 2020
Systemic Inflammation and Outcome in 2295 Patients with Stage I-III Colorectal Cancer from Scotland and Norway: First Results from the ScotScan Colorectal Cancer GroupJames H Park, Anniken J Fuglestad, Anne H Køstner, et al.Biomacromolecules|October 7, 2025
Surface Density of Mono- and Trivalent High-Mannan-Derived Targeting Structures with Different Affinities Impacts Cellular Uptake of Human Serum Albumin-Derived NanocarriersRobert Forster, Bellinda Lantzberg, Annabelle Weldert, et al.BMC Cancer|June 3, 2014
FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximabJanne B Kjersem, Eva Skovlund, Tone Ikdahl, et al.Pageof 10